Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Takuji Okusaka
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Concepts & Ideas
Procedures
Sign-in to see full Profile
Network (preview)
54
Ikeda, Masafumi
50
Ueno, Hideki
42
Okada, Shuichi
33
Morizane, Chigusa
25
Yoshimori, M
21
Furuse, Junji
19
Ishii, H
13
Nose, H
10
Nakasuka, H
9
Nagahama, H
8
Sakamoto, M
8
Takayasu, Kenichi
7
Takezako, Yoriko
7
Ishii, Hiroshi
6
Saijo, Nagahiro
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Takuji Okusaka (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Furuse Junji; Okusaka Takuji; Ohkawa Shinichi; Nagase Michitaka; Funakoshi Akihiro; Boku Narikazu; Yamao Kenji; Yamaguchi Taketo; Sato Toshiya
A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Cancer chemotherapy and pharmacology 2009;65(1):113-20.
-
2009: Seki Yoshitaka; Okusaka Takuji; Ikeda Masafumi; Morizane Chigusa; Ueno Hideki
Four cases of pancreatic acinar cell carcinoma treated with gemcitabine or S-1 as a single agent.
Japanese journal of clinical oncology 2009;39(11):751-5.
-
2009: Ono Masaya; Matsubara Junichi; Honda Kazufumi; Sakuma Tomohiro; Hashiguchi Tomoyo; Nose Hiroshi; Nakamori Shoji; Okusaka Takuji; Kosuge Tomoo; Sata Naohiro; Nagai Hideo; Ioka Tatsuya; Tanaka Sachiko; Tsuchida Akihiko; Aoki Tatsuya; Shimahara Masashi; Yasunami Yohichi; Itoi Takao; Moriyasu Fuminori; Negishi Ayako; Kuwabara Hideya; Shoji Ayako; Hirohashi Setsuo; Yamada Tesshi
Prolyl 4-hydroxylation of alpha-fibrinogen: a novel protein modification revealed by plasma proteomics.
The Journal of biological chemistry 2009;284(42):29041-9.
-
2009: Matsubara Junichi; Ono Masaya; Negishi Ayako; Ueno Hideki; Okusaka Takuji; Furuse Junji; Furuta Koh; Sugiyama Emiko; Saito Yoshiro; Kaniwa Nahoko; Sawada Junichi; Honda Kazufumi; Sakuma Tomohiro; Chiba Tsutomu; Saijo Nagahiro; Hirohashi Setsuo; Yamada Tesshi
Identification of a predictive biomarker for hematologic toxicities of gemcitabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(13):2261-8.
-
2009: Ueno H; Kaniwa N; Okusaka T; Ikeda M; Morizane C; Kondo S; Sugiyama E; Kim S R; Hasegawa R; Saito Y; Yoshida T; Saijo N; Sawada J
Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients.
British journal of cancer 2009;100(6):870-3.
-
2009: Morizane Chigusa; Okusaka Takuji; Furuse Junji; Ishii Hiroshi; Ueno Hideki; Ikeda Masafumi; Nakachi Kohei; Najima Mina; Ogura Takashi; Suzuki Eiichiro
A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer.
Cancer chemotherapy and pharmacology 2009;63(2):313-9.
-
2009: Hashimoto Kenji; Ueno Hideki; Ikeda Masafumi; Kojima Yasushi; Hagihara Atsushi; Kondo Shunsuke; Morizane Chigusa; Okusaka Takuji
Do recurrent and metastatic pancreatic cancer patients have the same outcomes with gemcitabine treatment?
Oncology 2009;77(3-4):217-23.
-
2008: Tanaka Tsutomu; Ikeda Masafumi; Okusaka Takuji; Ueno Hideki; Morizane Chigusa; Hagihara Atsushi; Iwasa Satoru; Kojima Yasushi
Prognostic factors in japanese patients with advanced pancreatic cancer treated with single-agent gemcitabine as first-line therapy.
Japanese journal of clinical oncology 2008;38(11):755-61.
-
2008: Ikeda Masafumi; Okusaka Takuji; Ueno Hideki; Morizane Chigusa; Kojima Yasushi; Iwasa Satoru; Hagihara Atsushi
Predictive factors of outcome and tumor response to systemic chemotherapy in patients with metastatic hepatocellular carcinoma.
Japanese journal of clinical oncology 2008;38(10):675-82.
-
2008: Furuse Junji; Okusaka Takuji; Boku Narikazu; Ohkawa Shinichi; Sawaki Akira; Masumoto Toshikazu; Funakoshi Akihiro
S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study.
Cancer chemotherapy and pharmacology 2008;62(5):849-55.
-
2008: Ohnami Shumpei; Sato Yasunori; Yoshimura Kimio; Ohnami Sumiko; Sakamoto Hiromi; Aoki Kazunori; Ueno Hideki; Ikeda Masafumi; Morizane Chigusa; Shimada Kazuaki; Sakamoto Yoshihiro; Esaki Minoru; Saito Ikuo; Hirose Hiroshi; Saito Daizo; Sugimura Haruhiko; Kosuge Tomoo; Okusaka Takuji; Yoshida Teruhiko
His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk.
Gastroenterology 2008;135(2):477-88.
-
2008: Takezako Yoriko; Okusaka Takuji; Ueno Hideki; Ikeda Masafumi; Morizane Chigusa; Najima Mina
Phase II study of cisplatin, epirubicin and continuous infusion of 5-fluorouracil in patients with advanced intrahepatic cholangiocellular carcinoma (ICC).
Hepato-gastroenterology 2008;55(85):1380-4.
-
2008: Okusaka Takuji; Ito Yoshinori; Furuse Junji; Yamada Shigeru; Ishii Hiroshi; Shibuya Keiko; Ioka Tatsuya; Shinchi Hiroyuki
Current status of chemoradiotherapy for locally advanced pancreatic cancer in Japan.
International journal of clinical oncology / Japan Society of Clinical Oncology 2008;13(2):127-31.
-
2008: Tanaka Tsutomu; Ikeda Masafumi; Okusaka Takuji; Ueno Hideki; Morizane Chigusa; Ogura Takashi; Hagihara Atsushi; Iwasa Satoru
A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
Cancer chemotherapy and pharmacology 2008;61(4):683-8.
-
2008: Okusaka Takuji; Funakoshi Akihiro; Furuse Junji; Boku Narikazu; Yamao Kenji; Ohkawa Shinichi; Saito Hiroshi
A late phase II study of S-1 for metastatic pancreatic cancer.
Cancer chemotherapy and pharmacology 2008;61(4):615-21.
-
2008: Kim Su-Ryang; Saito Yoshiro; Maekawa Keiko; Sugiyama Emiko; Kaniwa Nahoko; Ueno Hideki; Okusaka Takuji; Ikeda Masafumi; Morizane Chigusa; Yamamoto Noboru; Yoshida Teruhiko; Kamatani Naoyuki; Furuse Junji; Ishii Hiroshi; Saijo Nagahiro; Ozawa Shogo; Sawada Jun-Ichi
Twenty novel genetic variations and haplotype structures of the DCK gene encoding human deoxycytidine kinase (dCK).
Drug metabolism and pharmacokinetics 2008;23(5):379-84.
-
2008: Matsubara Junichi; Okusaka Takuji; Morizane Chigusa; Ikeda Masafumi; Ueno Hideki
Ultrasound-guided percutaneous pancreatic tumor biopsy in pancreatic cancer: a comparison with metastatic liver tumor biopsy, including sensitivity, specificity, and complications.
Journal of gastroenterology 2008;43(3):225-32.
-
2007: Yonemori Kan; Okusaka Takuji; Ueno Hideki; Morizane Chigusa; Takesako Yoriko; Ikeda Masafumi
FP therapy for controlling malignant ascites in advanced pancreatic cancer patients.
Hepato-gastroenterology 2007;54(80):2383-6.
-
2007: Yonemoto Naohiro; Furuse Junji; Okusaka Takuji; Yamao Kenji; Funakoshi Akihiro; Ohkawa Shinichi; Boku Narikazu; Tanaka Katsuaki; Nagase Michitaka; Saisho Hiromitsu; Sato Tosiya
A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer.
Japanese journal of clinical oncology 2007;37(11):843-51.
-
2007: Shimada Kazuaki; Sakamoto Yoshihiro; Esaki Minoru; Kosuge Tomoo; Morizane Chigusa; Ikeda Masafumi; Ueno Hideki; Okusaka Takuji; Arai Yasuaki; Takayasu Kenichi
Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma.
Annals of surgical oncology 2007;14(8):2337-47.
-
2007: Ueno Hideki; Okusaka Takuji; Ikeda Masafumi; Morizane Chigusa; Ogura Takashi; Hagihara Atsushi; Tanaka Tsutomu
Phase II study of combination chemotherapy with gemcitabine and cisplatin for patients with metastatic pancreatic cancer.
Japanese journal of clinical oncology 2007;37(7):515-20.
-
2007: Hamaguchi T; Kato K; Yasui H; Morizane C; Ikeda M; Ueno H; Muro K; Yamada Y; Okusaka T; Shirao K; Shimada Y; Nakahama H; Matsumura Y
A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation.
British journal of cancer 2007;97(2):170-6.
-
2007: Ikeda M; Okusaka T; Ito Y; Ueno H; Morizane C; Furuse J; Ishii H; Kawashima M; Kagami Y; Ikeda H
A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer.
British journal of cancer 2007;96(11):1650-5.
-
2007: Ueno Hideki; Okusaka Takuji; Funakoshi Akihiro; Ishii Hiroshi; Yamao Kenji; Ishikawa Osamu; Ohkawa Shinichi; Saitoh Soh
A phase II study of weekly irinotecan as first-line therapy for patients with metastatic pancreatic cancer.
Cancer chemotherapy and pharmacology 2007;59(4):447-54.
-
2007: Sugiyama Emiko; Kaniwa Nahoko; Kim Su-Ryang; Kikura-Hanajiri Ruri; Hasegawa Ryuichi; Maekawa Keiko; Saito Yoshiro; Ozawa Shogo; Sawada Jun-ichi; Kamatani Naoyuki; Furuse Junji; Ishii Hiroshi; Yoshida Teruhiko; Ueno Hideki; Okusaka Takuji; Saijo Nagahiro
Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(1):32-42.
-
2007: Ikeda Masafumi; Okusaka Takuji; Ueno Hideki; Morizane Chigusa; Iwasa Satoru; Hagihara Atsushi; Kojima Yasushi
Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis.
Oncology 2007;72(3-4):188-93.
-
2006: Kondo Shunsuke; Okusaka Takuji; Ueno Hideki; Ikeda Masafumi; Morizane Chigusa
Spontaneous regression of hepatocellular carcinoma.
International journal of clinical oncology / Japan Society of Clinical Oncology 2006;11(5):407-11.
-
2006: Ueno Hideki; Sato Tosiya; Yamamoto Seiichiro; Tanaka Katsuaki; Ohkawa Shinichi; Takagi Hitoshi; Yokosuka Osamu; Furuse Junji; Saito Hidetsugu; Sawaki Akira; Kasugai Hiroshi; Osaki Yukio; Fujiyama Shigetoshi; Sato Keiko; Wakabayashi Keiji; Okusaka Takuji
Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C.
Cancer science 2006;97(10):1105-10.
-
2006: Ito Yoshinori; Okusaka Takuji; Kagami Yoshikazu; Ueno Hideki; Ikeda Masafumi; Sumi Minako; Imai Atsushi; Fujimoto Naoko; Ikeda Hiroshi
Evaluation of acute intestinal toxicity in relation to the volume of irradiated small bowel in patients treated with concurrent weekly gemcitabine and radiotherapy for locally advanced pancreatic cancer.
Anticancer research 2006;26(5B):3755-9.
-
2006: Furuse Junji; Okusaka Takuji; Funakoshi Akihiro; Yamao Kenji; Nagase Michitaka; Ishii Hiroshi; Nakachi Kohei; Ueno Hideki; Ikeda Masafumi; Morizane Chigusa; Horikawa Yuki; Mizuno Nobumasa
Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
Japanese journal of clinical oncology 2006;36(9):552-6.
-
2006: Okusaka Takuji; Ishii Hiroshi; Funakoshi Akihiro; Ueno Hideki; Furuse Junji; Sumii Toshihiko
A phase I/II study of combination chemotherapy with gemcitabine and 5-fluorouracil for advanced pancreatic cancer.
Japanese journal of clinical oncology 2006;36(9):557-63.
-
2006: Takayasu Kenichi; Muramatsu Yukio; Mizuguchi Yasunori; Okusaka Takuji; Shimada Kazuaki; Takayama Tadatoshi; Sakamoto Michiie
CT Evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver disease.
AJR. American journal of roentgenology 2006;187(2):454-63.
-
2006: Okusaka Takuji; Ueno Hideki; Ikeda Masafumi; Morizane Chigusa
[S-1 monotherapy for pancreatic cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 2006;33 Suppl 1():207-12.
-
2006: Kim Su-Ryang; Saito Yoshiro; Maekawa Keiko; Sugiyama Emiko; Kaniwa Nahoko; Ueno Hideki; Okusaka Takuji; Morizane Chigusa; Yamamoto Noboru; Ikeda Masafumi; Yoshida Teruhiko; Minami Hironobu; Furuse Junji; Ishii Hiroshi; Saijo Nagahiro; Kamatani Naoyuki; Ozawa Shogo; Sawada Jun-ichi
Thirty novel genetic variations in the SLC29A1 gene encoding human equilibrative nucleoside transporter 1 (hENT1).
Drug metabolism and pharmacokinetics 2006;21(3):248-56.
-
2006: Okusaka Takuji; Ishii Hiroshi; Funakoshi Akihiro; Yamao Kenji; Ohkawa Shinichi; Saito Soh; Saito Hiroshi; Tsuyuguchi Toshio
Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer.
Cancer chemotherapy and pharmacology 2006;57(5):647-53.
-
2006: Okusaka Takuji; Ueno Hideki; Ikeda Masafumi; Morizane Chigusa
[Non-surgical treatment for pancreatic cancer]
Nippon Shokakibyo Gakkai zasshi The Japanese journal of gastro-enterology 2006;103(4):391-7.
-
2006: Takayasu Kenichi; Muramatsu Yukio; Mizuguchi Yasunori; Moriyama Noriyuki; Okusaka Takuji
Multiple non-tumorous arterioportal shunts due to chronic liver disease mimicking hepatocellular carcinoma: outcomes and the associated elevation of alpha-fetoprotein.
Journal of gastroenterology and hepatology 2006;21(1 Pt 2):288-94.
-
2006: Ikeda Masafumi; Najima Mina; Morizane Chigusa; Ueno Hideki; Okusaka Takuji
[Palliative therapy in patients with biliary tract cancer]
Nippon rinsho. Japanese journal of clinical medicine 2006;64 Suppl 1():565-7.
-
2006: Morizane Chigusa; Okusaka Takuji; Ueno Hideki; Ikeda Masafumi
[5 -fluoropyrimidines for treatment of biliary tract cancers]
Nippon rinsho. Japanese journal of clinical medicine 2006;64 Suppl 1():529-33.
-
2006: Najima Mina; Okusaka Takuji
[Tumor markers in biliary tract cancer]
Nippon rinsho. Japanese journal of clinical medicine 2006;64 Suppl 1():419-21.
-
2006: Okusaka Takuji; Yamada Tesshi; Maekawa Masato
Serum tumor markers for pancreatic cancer: the dawn of new era?
JOP : Journal of the pancreas 2006;7(4):332-6.
-
2005: Furuse Junji; Ishii Hiroshi; Okusaka Takuji; Nagase Michitaka; Nakachi Kohei; Ueno Hideki; Ikeda Masafumi; Morizane Chigusa; Yoshino Masahiro
Phase I study of fixed dose rate infusion of gemcitabine in patients with unresectable pancreatic cancer.
Japanese journal of clinical oncology 2005;35(12):733-8.
-
2005: Saisho Toshimitsu; Okusaka Takuji; Ueno Hideki; Morizane Chigusa; Okada Shuichi
Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
Hepato-gastroenterology 2005;52(66):1654-8.
-
2005: Honda Kazufumi; Hayashida Yasuharu; Umaki Tomoko; Okusaka Takuji; Kosuge Tomoo; Kikuchi Satoru; Endo Mitsufumi; Tsuchida Akihiko; Aoki Tatsuya; Itoi Takao; Moriyasu Fuminori; Hirohashi Setsuo; Yamada Tesshi
Possible detection of pancreatic cancer by plasma protein profiling.
Cancer research 2005;65(22):10613-22.
-
2005: Ikeda Masafumi; Okusaka Takuji; Ueno Hideki; Morizane Chigusa; Furuse Junji; Ishii Hiroshi
A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma.
Japanese journal of clinical oncology 2005;35(8):439-43.
-
2005: Yonemori Kan; Ueno Hideki; Okusaka Takuji; Yamamoto Noboru; Ikeda Masafumi; Saijo Nagahiro; Yoshida Teruhiko; Ishii Hiroshi; Furuse Junji; Sugiyama Emiko; Kim Su-Ryang; Kikura-Hanajiri Ruri; Hasegawa Ryuichi; Saito Yoshiro; Ozawa Shogo; Kaniwa Nahoko; Sawada Jun-Ichi
Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatin.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(7):2620-4.
-
2005: Ikeda Masafumi; Okusaka Takuji; Ueno Hideki; Takezako Yoriko; Morizane Chigusa
A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma.
Cancer 2005;103(4):756-62.
-
2005: Ueno Hideki; Okusaka Takuji; Ikeda Masafumi; Ishiguro Yoriko; Morizane Chigusa; Matsubara Junichi; Furuse Junji; Ishii Hiroshi; Nagase Michitaka; Nakachi Kohei
A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer.
Oncology 2005;69(5):421-7.
-
2005: Morizane Chigusa; Okusaka Takuji; Ito Yoshinori; Ueno Hideki; Ikeda Masafumi; Takezako Yoriko; Kagami Yoshikazu; Ikeda Hiroshi
Chemoradiotherapy for locally advanced pancreatic carcinoma in elderly patients.
Oncology 2005;68(4-6):432-7.
-
2005: Ueno Hideki; Okusaka Takuji; Ikeda Masafumi; Takezako Yoriko; Morizane Chigusa
An early phase II study of S-1 in patients with metastatic pancreatic cancer.
Oncology 2005;68(2-3):171-8.
-
2004: Okusaka Takuji; Ueno Hideki; Ikeda Masafumi
[Chemotherapy for hepatocellular carcinoma]
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(13):2122-8.
-
2004: Ueno H; Okusaka T; Ikeda M; Takezako Y; Morizane C
Phase II study of S-1 in patients with advanced biliary tract cancer.
British journal of cancer 2004;91(10):1769-74.
-
2004: Takezako Yoriko; Okusaka Takuji; Ueno Hideki; Ikeda Masahumi; Morizane Chigusa; Najima Mina
[Tumor markers for pancreatic and biliary tract cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(9):1443-6.
-
2004: Okusaka Takuji; Matsumura Yasuhiro; Aoki Kazunori
New approaches for pancreatic cancer in Japan.
Cancer chemotherapy and pharmacology 2004;54 Suppl 1():S78-82.
-
2004: Okusaka T; Ito Y; Ueno H; Ikeda M; Takezako Y; Morizane C; Kagami Y; Ikeda H
Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer.
British journal of cancer 2004;91(4):673-7.
-
2004: Okusaka Takuji; Kosuge Tomoo
Systemic chemotherapy for pancreatic cancer.
Pancreas 2004;28(3):301-4.
-
2004: Okusaka Takuji; Okada Shuichi; Nakanishi Toshio; Fujiyama Shigetoshi; Kubo Yasuhiko
Phase II trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinoma.
Investigational new drugs 2004;22(2):169-76.
-
2004: Ueno Hideki; Okusaka Takuji; Ikeda Masafumi; Tokuuye Koich
Phase I study of hyperfractionated radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic cancer.
Oncology 2004;67(3-4):215-21.
-
2003: Tokuuye Koichi; Sumi Minako; Kagami Yoshikazu; Murayama Shigeyuki; Ikeda Hiroshi; Ikeda Masafumi; Okusaka Takuji; Ueno Hideki; Okada Shuichi
Small-field radiotherapy in combination with concomitant chemotherapy for locally advanced pancreatic carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;67(3):327-30.
-
2003: Morizane Chigusa; Okada Shuichi; Okusaka Takuji; Ueno Hideki; Saisho Toshimitsu
Phase II study of cisplatin, epirubicin, and continuous-infusion 5-fluorouracil for advanced biliary tract cancer.
Oncology 2003;64(4):475-6.
-
2002: Okusaka Takuji
Chemotherapy for biliary tract cancer in Japan.
Seminars in oncology 2002;29(6 Suppl 20):51-3.
-
2002: Ikeda Masafumi; Okada Shuichi; Yamamoto Seiichiro; Sato Tosiya; Ueno Hideki; Okusaka Takuji; Kuriyama Hitoshi; Takayasu Kenichi; Furukawa Hiroyoshi; Iwata Ryoko
Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization.
Japanese journal of clinical oncology 2002;32(11):455-60.
-
2002: Kuriyama Hitoshi; Okada Shuichi; Okusaka Takuji; Ueno Hideki; Ikeda Masafumi
Prognostic factors in patients with small hepatocellular carcinoma treated by percutaneous ethanol injection.
Journal of gastroenterology and hepatology 2002;17(11):1205-10.
-
2002: Okusaka Takuji; Okada Shuichi; Ueno Hideki; Ikeda Masafumi; Shimada Kazuaki; Yamamoto Junji; Kosuge Tomoo; Yamasaki Susumu; Fukushima Noriyoshi; Sakamoto Michiie
Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features.
Cancer 2002;95(9):1931-7.
-
2002: Okada Shuichi; Tanaka Katsuaki; Sato Tosiya; Ueno Hideki; Saito Satoru; Okusaka Takuji; Sato Keiko; Yamamoto Seiichiro; Kakizoe Tadao
Dose-response trial of lactoferrin in patients with chronic hepatitis C.
Japanese journal of cancer research : Gann 2002;93(9):1063-9.
-
2002: Ikeda M; Okada S; Tokuuye K; Ueno H; Okusaka T
A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer.
British journal of cancer 2002;86(10):1551-4.
-
2002: Ueno Hideki; Okada Shuichi; Okusaka Takuji; Ikeda Masafumi; Kuriyama Hitoshi
Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma.
Cancer chemotherapy and pharmacology 2002;49(2):155-60.
-
2002: Okusaka Takuji; Okada Shuichi; Ueno Hideki; Ikeda Masafumi; Iwata Ryoko; Furukawa Hiroyoshi; Takayasu Kenichi; Moriyama Noriyuki; Sato Tosiya; Sato Keiko
Transcatheter arterial embolization with zinostatin stimalamer for hepatocellular carcinoma.
Oncology 2002;62(3):228-33.
-
2002: Ueno Hideki; Okada Shuichi; Okusaka Takuji; Ikeda Masafumi; Kuriyama Hitoshi
Phase II study of uracil-tegafur in patients with metastatic pancreatic cancer.
Oncology 2002;62(3):223-7.
-
2001: Ikeda M; Okada S; Ueno H; Okusaka T; Kuriyama H
Spontaneous regression of hepatocellular carcinoma with multiple lung metastases: a case report.
Japanese journal of clinical oncology 2001;31(9):454-8.
-
2001: Ueno H; Okada S; Okusaka T; Ikeda M; Tanaka N; Sakamoto M; Yoshimori M
Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
Hepato-gastroenterology 2001;48(41):1430-4.
-
2001: Ikeda M; Okada S; Ueno H; Okusaka T; Kuriyama H
Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study.
Japanese journal of clinical oncology 2001;31(7):322-6.
-
2001: Okusaka T; Okada S; Ueno H; Ikeda M; Shimada K; Yamamoto J; Kosuge T; Yamasaki S; Fukushima N; Sakamoto M
Abdominal pain in patients with resectable pancreatic cancer with reference to clinicopathologic findings.
Pancreas 2001;22(3):279-84.
-
2001: Okusaka T; Okada S; Tokuuye K; Wakasugi H; Saisho H; Ishikawa O; Matsuno S; Sato T; Sato K;
Lack of effectiveness of radiotherapy combined with cisplatin in patients with locally advanced pancreatic carcinoma.
Cancer 2001;91(7):1384-9.
-
2001: Takayasu K; Muramatsu Y; Maeda T; Iwata R; Furukawa H; Muramatsu Y; Moriyama N; Okusaka T; Okada S; Ueno H
Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates.
AJR. American journal of roentgenology 2001;176(3):681-8.
-
2001: Ikeda M; Okada S; Tokuuye K; Ueno H; Okusaka T
Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy.
Cancer 2001;91(3):490-5.
-
2001: Okada S; Ueno H; Okusaka T; Ikeda M; Furuse J; Maru Y
Phase I trial of gemcitabine in patients with advanced pancreatic cancer.
Japanese journal of clinical oncology 2001;31(1):7-12.
-
2000: Fujishiro M; Okada S; Ueno H; Okusaka T; Ikeda M; Watanabe H; Tanaka N
Predictive factors for tumor response to chemotherapy in patients with pancreatic cancer.
Hepato-gastroenterology 2000;47(36):1744-6.
-
2000: Ueno H; Okada S; Okusaka T; Ikeda M
Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy.
Oncology 2000;59(4):296-301.
-
2000: Tokuuye K; Sumi M; Kagami Y; Murayama S; Kawashima M; Ikeda H; Ueno H; Okusaka T; Okada S
Radiotherapy for hepatocellular carcinoma.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2000;176(9):406-10.
-
2000: Ikeda M; Okada S; Ueno H; Okusaka T; Tanaka N; Kuriyama H; Yoshimori M
A phase II study of sequential methotrexate and 5-fluorouracil in metastatic pancreatic cancer.
Hepato-gastroenterology 2000;47(33):862-5.
-
2000: Okusaka T; Okada S; Ueno H; Ikeda M; Yoshimori M; Shimada K; Yamamoto J; Kosuge T; Yamasaki S; Iwata R; Furukawa H; Moriyama N; Sakamoto M; Hirohashi S
Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma.
Oncology 2000;58(4):293-9.
-
2000: Tanaka N; Okada S; Ueno H; Okusaka T; Ikeda M
The usefulness of serial changes in serum CA19-9 levels in the diagnosis of pancreatic cancer.
Pancreas 2000;20(4):378-81.
-
1999: Nose H; Okada S; Okusaka T; Furuse J; Yoshino M; Ogoshi K; Kato T; Miyaji M; Hoshino M; Ariyama J; Suyama M; Karasawa E; Yoshimori M
5-fluorouracil continuous infusion combined with cisplatin for advanced pancreatic cancer: a Japanese Cooperative Study.
Hepato-gastroenterology 1999;46(30):3244-8.
-
1999: Nagahama H; Okada S; Okusaka T; Ishii H; Ikeda M; Nakasuka H; Yoshimori M
Clinicopathological features in misdiagnosed pancreatic carcinoma.
Hepato-gastroenterology 1999;46(29):2983-5.
-
1999: Kosakamoto H; Okada S; Ueno H; Okusaka T; Ikeda M; Tanaka N; Yoshimori M; Matsuno Y
A case of pancreatic cancer achieving symptomatic improvement with systemic chemotherapy.
Hepato-gastroenterology 1999;46(28):2621-4.
-
1998: Okusaka T; Okada S; Ishii H; Ikeda M; Nakasuka H; Nagahama H; Iwata R; Furukawa H; Takayasu K; Nakanishi Y; Sakamoto M; Hirohashi S; Yoshimori M
Transarterial chemotherapy with zinostatin stimalamer for hepatocellular carcinoma.
Oncology 1998;55(4):276-83.
-
1998: Nakasuka H; Okada S; Okusaka T; Ishii H; Ikeda M; Ito R; Kosakamoto H; Yoshimori M; Nakanishi Y; Sakamoto M
Undifferentiated carcinoma of the liver with neuroendocrine features: a case report.
Japanese journal of clinical oncology 1998;28(6):401-4.
-
1998: Okada S; Sato T; Okusaka T; Ishii H; Ikeda M; Nakasuka H; Kosakamoto H; Yoshimori M; Wakabayashi K
Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease.
British journal of cancer 1998;77(11):2028-31.
-
1998: Okusaka T; Okada S; Sato T; Wakasugi H; Saisho H; Furuse J; Ishikawa O; Matsuno S; Yokoyama S
Tumor markers in evaluating the response to radiotherapy in unresectable pancreatic cancer.
Hepato-gastroenterology 1998;45(21):867-72.
-
1998: Ishii H; Okada S; Okusaka T; Yoshimori M; Nakasuka H; Shimada K; Yamasaki S; Nakanishi Y; Sakamoto M
Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection.
Cancer 1998;82(9):1638-42.
-
1998: Okada S; Okusaka T; Ishii H; Kyogoku A; Yoshimori M; Kajimura N; Yamaguchi K; Kakizoe T
Elevated serum interleukin-6 levels in patients with pancreatic cancer.
Japanese journal of clinical oncology 1998;28(1):12-5.
-
1998: Okusaka T; Okada S; Ishii H; Ikeda M; Kosakamoto H; Yoshimori M
Prognosis of advanced pancreatic cancer patients with reference to calorie intake.
Nutrition and cancer 1998;32(1):55-8.
-
1997: Okusaka T; Okada S; Ishii H; Nagahama H; Yoshimori M; Yamasaki S; Takayasu K; Kakizoe T; Ochiai A; Shimoda T
Hepatocellular carcinoma with gastrointestinal hemorrhage caused by direct tumor invasion to the duodenum.
Japanese journal of clinical oncology 1997;27(5):343-5.
-
1997: Nagahama H; Okada S; Okusaka T; Ishii H; Ikeda M; Nakasuka H; Yoshimori M
Predictive factors for tumor response to systemic chemotherapy in patients with hepatocellular carcinoma.
Japanese journal of clinical oncology 1997;27(5):321-4.
-
1997: Ishii H; Okada S; Tokuuye K; Nose H; Okusaka T; Yoshimori M; Nagahama H; Sumi M; Kagami Y; Ikeda H
Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma.
Cancer 1997;79(8):1516-20.
-
1997: Okada S; Ishii H; Nose H; Okusaka T; Kyogoku A; Yoshimori M; Wakabayashi K
Evidence for increased somatic cell mutations in patients with hepatocellular carcinoma.
Carcinogenesis 1997;18(2):445-9.
-
1997: Okusaka T; Eguchi K; Kasai T; Kurata T; Yamamoto N; Ohe Y; Tamura T; Shinkai T; Saijo N
Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(1):123-7.
-
1997: Okusaka T; Okada S; Ishii H; Nose H; Nagahama H; Nakasuka H; Ikeda K; Yoshimori M
Prognosis of hepatocellular carcinoma patients with extrahepatic metastases.
Hepato-gastroenterology 1997;44(13):251-7.
-
1996: Okada S; Ishii H; Nose H; Okusaka T; Kyogoku A; Yoshimori M; Shimada K; Yamamoto J; Kosuge T; Yamasaki S; Sakamoto M; Hirohashi S
Effect of heavy alcohol intake on long-term results after curative resection of hepatitis C virus-related hepatocellular carcinoma.
Japanese journal of cancer research : Gann 1996;87(8):867-73.
-
1996: Okusaka T; Okada S; Ishii H; Nose H; Nakasuka H; Nakayama H; Nagahama H
Clinical response to systemic combined chemotherapy with 5-fluorouracil and cisplatin (FP therapy) in patients with advanced pancreatic cancer.
Japanese journal of clinical oncology 1996;26(4):215-20.
-
1996: Ishii H; Okada S; Nose H; Okusaka T; Nagahama H; Nakayama H; Nakasuka H; Yoshimori M
Predictive factors for recurrence after percutaneous ethanol injection for solitary hepatocellular carcinoma.
Hepato-gastroenterology 1996;43(10):938-43.
-
1996: Okusaka T; Okada S; Nose H; Ishii H; Nakasuka H; Nakayama H; Nagahama H; Yoshimori M; Shimada K; Yamamoto J; Takayama T; Kosuge T; Yamasaki S; Sakamoto M; Hirohashi S
The prognosis of patients with hepatocellular carcinoma of multicentric origin.
Hepato-gastroenterology 1996;43(10):919-25.
-
1996: Ishii H; Okada S; Sato T; Nose H; Okusaka T; Yoshimori M; Takayasu K; Takayama T; Kosuge T; Yamasaki S
Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization.
Hepato-gastroenterology 1996;43(9):644-50.
-
1996: Ishii H; Okada S; Nose H; Okusaka T; Yoshimori M; Takayama T; Kosuge T; Yamasaki S; Sakamoto M; Hirohashi S
Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection.
Cancer 1996;77(9):1792-6.
-
1996: Ishii H; Okada S; Nose H; Yoshimori M; Aoki K; Okusaka T
Prognostic factors in patients with advanced pancreatic cancer treated with systemic chemotherapy.
Pancreas 1996;12(3):267-71.
-
1995: Okada S; Ishii H; Nose H; Okusaka T; Kyogoku A; Yoshimori M; Sakamoto M; Hirohashi S
Intratumoral DNA heterogeneity of small hepatocellular carcinoma.
Cancer 1995;75(2):444-50.
-
1994: Okada S; Ishii H; Nose H; Yoshimori M; Okusaka T; Aoki K; Iwasaki M; Furuse J; Yoshino M
A phase II study of cisplatin in patients with biliary tract carcinoma.
Oncology 1994;51(6):515-7.
Sign-in to see more
